Thomas Steyer’s St Jude Medical STJ Stock Holding History

Thomas Steyer’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-8,880,000	Closed	-$712M	–	88
2016 Q4	$712M	Sell	8,880,000 -250,000	-3%	-$19.8M	8.2%	2
2016 Q3	$728M	Buy	9,130,000 +4,530,000	+98%	+$366M	10.64%	2
2016 Q2	$359M	Buy	+4,600,000	New	+$328M	4.93%	3

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 3.61% 1-Year Est. Return

Thomas Steyer's STJ Position: Q1 2017 in Review

Thomas Steyer sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 8,880,000 shares — an estimated $712M sold.

Thomas Steyer first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $728M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Thomas Steyer reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Thomas Steyer sold 8,880,000 St Jude Medical shares in Q1 2017, an estimated $712M.
Thomas Steyer first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
Thomas Steyer's St Jude Medical position peaked at $728M in Q3 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Farallon Capital Management's 13F filing for Q1 2017, filed 15 May 2017.